Copyright © 1998 by the European Society of Cardiology.
Mitochondrial DNA in idiopathic cardiomyopathy
a University Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, London
c Department of Cardiology, Chelsea and Westminster Hospital, London
b Department of Cardiac Medicine, National Heart and Lung Institute at Imperial College School of Medicine, London
d University Department of Clinical Neurology, Institute of Neurology, London, U.K.
accepted May 6, 1998
Aims
To investigate the frequency of pathogenic mitochondrial DNA mutations in idiopathic cardiomyopathy.
Methods and Results
We investigated the occurrence of seven previously reported pathogenic mitochondrial DNA point mutations in 52 patients with idiopathic dilated cardiomyopathy (blood n=33, myocardium n=19), 10 patients with hypertrophic cardiomyopathy (blood n=7, myocardium n=3), 67 controls with ischaemic heart disease (blood n=53, myocardium n=14) and eight controls with no overt cardiac disease (blood n=4, myocardium n=4). Total DNA or cell lysates were studied by polymerase chain reaction amplification and restriction fragment length polymorphism analysis for the identification of the following mitochondrial DNA point mutations: A3243G, A3252G, A3260G, A4269G, A8344G, T8993G/C and T9997C. None of these point mutations were detected in the blood or myocardium of any of the individuals with dilated or hypertrophic cardiomyopathy or in the controls. In addition we investigated the occurrence of major deletions of mitochondrial DNA in eight patients with dilated cardiomyopathy (myocardium n=7, skeletal muscle n=1), three patients with ischaemic heart disease (myocardium n=3) and one control myocardium by Southern blot analysis. Deletions were not detected in any of the patients.
Conclusion
The results suggest that although these mutations are known to be associated with specific cardio-myopathies, they are not a common feature of idiopathic cardiomyopathy.The European Society of Cardiology
Key Words: Idiopathic dilated cardiomyopathy • hypertrophic cardiomyopathy • ischaemic heart disease • mitochondrial DNA • mitochondria
f1 Correspondence:Prof. A. H. V. Schapira, University Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, Rowland Hill Street, London NW3 2PF, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Fosslien Mitochondrial Medicine - Cardiomyopathy Caused by Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 371 - 395. [Abstract] [Full Text] [PDF]
|
|